C

Corcept Therapeutics

D
CORT
USD
-1.34
(-3.1739%)
Market Closed
41,281.00
Volume
0.78
EPS
-
Div Yield
36.177
P/E
4,271,652,132.72
Market Cap
Today
-3.1739%
1 Week
14.510%
1 Month
18.527%
6 Months
68.786%
12 Months
23.954%
Year To Date
25.785%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
B
BIIB
3.82
(1.9334%)
USD
GILD
GILD
0.015
(0.0179%)
USD
I
INCY
1.67
(2.5625%)
USD
J
JAZZ
1.66
(1.5152%)
USD
AMGN
AMGN
3.02
(0.9071%)
USD
REGN
REGN
11.33
(0.9948%)
USD
VRTX
VRTX
3.93
(0.8292%)
USD
B
BMRN
0.31
(0.4359%)
USD

Title:
Corcept Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Do you need help or have a question?
Contact Us